Related Experiment Video
Updated: Oct 27, 2025
04:29
Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
29.0K
Ketamine: Safe and Effective Treatment for Severe Depression
1Thomas Bradley Koss, DNAP, CRNA, APRN, Vanderbilt University Medical Center, Nashville, TN, USA.
Journal of the American Psychiatric Nurses Association
|July 20, 2021
Summary
An educational video highlights the safety and efficacy of low-dose ketamine infusions for treatment-resistant depression. This accessible resource aims to inform patients and providers about ketamine as an alternative therapy.
Area of Science:
- Psychiatry
- Pharmacology
- Medical Education
Background:
- Treatment-resistant depression significantly impairs quality of life.
- Ketamine presents a safe and effective alternative for depression management.
- Patient and provider awareness of ketamine therapy is limited.
Purpose of the Study:
- Disseminate information on the safety and efficacy of outpatient low-dose ketamine infusions.
- Educate on ketamine as an alternative therapy for treatment-resistant depression.
- Increase awareness among patients and healthcare providers.
Main Methods:
- Conducted a literature review in PubMed, PsychINFO, CINAHL, and Google Scholar.
- Developed an educational video on ketamine safety and efficacy for depression.
- Launched the video on YouTube and Facebook to assess reach and engagement.
Main Results:
- The video garnered 156 views, 60 likes, 8 shares, and 4 comments within 9 months.
- Viewer comments indicated the video was informative and encouraging.
- Social media platforms facilitated information dissemination.
Conclusions:
- An evidence-based educational video effectively informs about ketamine infusions for depression.
- Low-dose ketamine infusions offer a viable treatment option for patients unresponsive to conventional medications.
- Outpatient ketamine clinics provide crucial support for treatment-resistant depression.
More Related Videos
Related Concept Videos
01:30Electroconvulsive Therapy
304
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
304
01:24Parenteral Anesthetics: Overview
351
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
351
01:17Sedatives and Hypnotics Drugs: Miscellaneous Agents
296
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
296
01:23Antidepressant Drugs: MAOIs and Other Agents
491
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
491
01:28Drug Therapy
126
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
126
01:20Sedatives and Hypnotics Drugs: Barbiturates
601
Sedatives and hypnotics encompass a drug class that acts on the central nervous system (CNS) to alleviate anxiety, promote relaxation and induce sleep.These drugs function by amplifying the actions of the neurotransmitter γ-aminobutyric acid (GABA), resulting in reduced neuronal activity. Barbiturates, a subset of sedatives and hypnotics first synthesized in the late 1800s, are categorized into ultra-short, short, intermediate, and long-acting groups based on their duration of effect. A...
601